Compound Profile: T3 25 Maha Pharma
T3 25 Maha Pharma is a synthetic liothyronine sodium formulation designed specifically for in-vitro laboratory research applications. Liothyronine sodium represents the synthetic form of triiodothyronine (T3), the most metabolically active thyroid hormone that regulates cellular energy expenditure, protein synthesis, and metabolic rate in biological systems. This pharmaceutical-grade research compound enables researchers at Stroid UK Shop to investigate thyroid hormone receptor binding mechanisms, cellular thermogenesis pathways, and metabolic regulatory cascades. Each tablet contains precisely measured liothyronine sodium concentrations, manufactured under stringent quality control protocols to ensure consistency across experimental parameters. The compound’s molecular structure allows for comprehensive analysis of T3 receptor activation, mitochondrial biogenesis stimulation, and metabolic enzyme expression modulation in controlled research environments.
Laboratory Applications
Research applications for T3 25 include investigating thyroid hormone receptor (TR) binding affinities across different tissue types, examining cellular oxygen consumption rates, and analysing metabolic pathway activation mechanisms. Scientists utilise this compound to study thermogenic protein expression, uncoupling protein activation, and adipocyte lipolysis mechanisms in cellular models. The formulation proves valuable for metabolism research, investigating how thyroid hormones influence carbohydrate oxidation, lipid metabolism, and protein turnover rates. Researchers examining fat burner compounds often incorporate liothyronine sodium studies to understand metabolic enhancement mechanisms. Cross-referencing with SARMs research provides insights into synergistic metabolic effects, while comparative studies with peptide compounds elucidate complementary hormonal pathway interactions. The compound’s research applications extend to investigating circadian rhythm effects on metabolic rate, temperature regulation mechanisms, and cellular energy production optimisation.
Product Specifications
| Chemical Name | Liothyronine Sodium |
|---|---|
| CAS Number | 55-06-1 |
| Molecular Formula | C₁₅H₁₁I₃NNaO₄ |
| Molecular Weight | 672.96 g/mol |
| Concentration | 25 mcg per tablet |
| Storage Conditions | Room temperature, dry environment |
| Manufacturer | Maha Pharma |
| Research Grade | Pharmaceutical standard |
Research Use Compliance
T3 25 Maha Pharma is manufactured exclusively for in-vitro research purposes and laboratory analysis applications. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional review protocols and maintain appropriate laboratory safety standards when handling this compound. All experimental applications should follow established research methodologies and proper waste disposal procedures. Purchase and use of this research chemical implies acknowledgment of its laboratory-only designation and commitment to responsible research practices.
